Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors
نویسندگان
چکیده
منابع مشابه
Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.
PURPOSE Hepatoma-derived growth factor (HDGF) is a nucleus-targeted growth factor playing an important role in the development and progression of cancers. This study investigated the correlation of HDGF expression and prognosis in patients with pancreatic ductal carcinoma. PATIENTS AND METHODS HDGF expression in pancreatic cancer cell lines was analyzed by Western blotting. HDGF expression wa...
متن کاملPrognostic Role of Hepatoma-derived Growth Factor in Solid Tumors of Eastern Asia: A Meta-Analysis
GLOBOCAN 2012 showed that the new cases and deaths of cancers were respectively increased by 11.02% and 1.08% in 2012 compared with 2008. Despite the introduction of hundreds of new anticancer drugs, the consensus is that, for most forms of cancer, enduring disease-free responses are rare, and cures even rarer (Hanahan, 2014). The clinical outcome is disillusionary (Woodward, 2014) mainly due t...
متن کاملHepatoma-Derived Growth Factor-Related Protein-3 Is a Novel Angiogenic Factor
Hepatoma-derived growth factor-related protein-3 (Hdgfrp3 or HRP-3) was recently reported as a neurotrophic factor and is upregulated in hepatocellular carcinoma to promote cancer cell survival. Here we identified HRP-3 as a new endothelial ligand and characterized its in vitro and in vivo functional roles and molecular signaling. We combined open reading frame phage display with multi-round in...
متن کاملInsulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c-KIT and PDGFRalpha. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib-based therapies and have a poor prognosis. We identified amplification of IGF1R in a SNP analysis of GIST and thus studied its potential as a therapeutic target in WT and mutant GIST. Expression of IGF1R and down...
متن کاملEfficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors
PURPOSE The incidence of gastrointestinal stromal tumors (GISTs) harboring platelet-derived growth factor receptor alpha (PDGFRA) mutations is low, therefore further investigation of the efficacy of imatinib in this subgroup was needed. MATERIALS AND METHODS Patients with PDGFRA-mutant GISTs who received imatinib as primary therapy for advanced disease between January 2000 and June 2012 were ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Cancer
سال: 2007
ISSN: 0020-7136,1097-0215
DOI: 10.1002/ijc.22803